Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aryl Hydrocarbon Receptor
100%
Chronic Intermittent Hypoxia
83%
Hypoxia Condition
50%
Hypertension
45%
Cytochrome P450 1A1 (CYP1A1)
40%
Mercapturate Pathway
33%
Ketamine
33%
Biotransformation
33%
In Vivo Experiment
33%
Kidney
21%
Obstructive Sleep Apnea
21%
Canonical Pathway
20%
Arterial Hypertension
19%
Druggable Targets
19%
Kidney Cortex
18%
Non-communicable Diseases
16%
Cysteine Disulfide
16%
Cysteine Redox State
16%
Health Diseases
16%
Diabetic Kidney Disease
16%
Adaptive Mechanism
16%
Beta-blockers
16%
Redox Dynamics
16%
In Vivo Evidence
16%
Blockage
16%
Non-invasive Approach
16%
Black Presence
16%
Mercapturates
14%
Cysteine
13%
Blood Pressure
12%
Aryl Hydrocarbon Receptor Antagonist
11%
Rat Model
11%
Medetomidine
9%
Normoxia
8%
Sulfide Stress
8%
Intermittent Hypoxia
8%
Renal Tubular Epithelial Cells
8%
N-acetyltransferase 2 (NAT2)
8%
Kidney Disease
8%
Inactive Period
8%
Apps for Mobile Devices
8%
Storytelling Technique
8%
Black Experience
8%
Urban Routes
8%
Liver
8%
Metabolic
7%
Abrogation
6%
Circuitry
6%
Cysteine Conjugates
6%
Hydroxynorketamine
6%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatic Hydrocarbon Receptor
83%
Chronic Intermittent Hypoxia
83%
Cysteine
33%
Ketamine
33%
Sleep Disordered Breathing
24%
Cytochrome P450 1A1
22%
Diseases
19%
Non Communicable Disease
16%
Disulfide
16%
Rat Model
10%
Receptor Antagonist
10%
Glutathione
8%
Malignant Neoplasm
8%
Inflammatory Disease
8%
Environmental Exposure
8%
Electrophile
8%
Intermittent Hypoxia
8%
Acyltransferase
6%
Cystine
5%
Antihypertensive Agent
5%
